04.11.2012 • News

Applikon, Thermo Fisher Sign Bilateral Supply Agreement

Applikon Biotechnology, a global supplier of bioreactor control systems to the biopharma market, today announced the signing of a bilateral supply agreement with Thermo Fisher Scientific.

As part of the agreement, Thermo Fisher and Applikon have developed an integrated solution that combines the Thermo Scientific HyClone Single-Use Bioreactor (S.U.B.) with the Applikon ez- and i-Control systems.

Thermo Scientific will resell this solution under the Thermo Scientific HyPerforma product suite. Applikon will resell the S.U.B. as a integrated solution.

 

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.